Trial NCT03604991

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2018-01575
Secondary IDs: EA2174 NCI-2018-01575 U10CA180820

Last trial update was posted on 2024-04-16

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Ipilimumab Nivolumab Paclitaxel

MeSH Conditions

Adenocarcinoma Esophageal Neoplasms

Other Conditions

Clinical Stage II Esophageal Adenocarcinoma AJCC v8 Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage III Esophageal Adenocarcinoma AJCC v8 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Esophageal Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Stopping Reasons

End of Initial Phase of Multi-phase protocol

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID